MicroRNAs in infectious diseases: potential diagnostic biomarkers and therapeutic targets

Muneyoshi Kimura1, Sagar Kothari1, Wajiha Gohir1

  • 1Transplant Infectious Diseases, Ajmera Transplant Program, University Health Network, Toronto, Ontario, Canada.

PubMed

Insights

MicroRNAs (miRNAs) regulate gene expression and immune responses during infections. This review explores their clinical roles as biomarkers and therapeutic targets in various infectious diseases.

Area of Science:

  • Molecular Biology
  • Immunology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are short, non-coding RNAs regulating gene expression post-transcriptionally.
  • miRNAs are implicated in various diseases, including cancer and autoimmune disorders.
  • Emerging evidence highlights miRNAs' critical roles in immune cell development and host defense.

Purpose of the Study:

  • To review the clinical significance of miRNAs in infectious diseases.
  • To elucidate the functional mechanisms of miRNAs during infection.
  • To assess the potential of miRNAs as diagnostic biomarkers and therapeutic targets.

Main Methods:

  • Literature review of studies on miRNAs in viral, fungal, bacterial, and parasitic infections.
  • Analysis of miRNA dysregulation in response to infection.
  • Evaluation of clinical implications and therapeutic potential.

Main Results:

  • miRNA expression changes significantly during infections, impacting immune responses.
  • Dysregulated miRNAs influence protein expression, affecting disease progression and severity.
  • miRNAs demonstrate potential as biomarkers for diagnosing and predicting infectious diseases.

Conclusions:

  • miRNAs are crucial regulators of the immune system during infections.
  • Targeting miRNAs offers a promising strategy for novel diagnostics and therapeutics against infectious agents.
  • Further research is warranted to fully harness the clinical potential of miRNAs in infectious disease management.

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
35
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K